Literature DB >> 17275019

Flow cytometry for basophil activation markers: the measurement of CD203c up-regulation is as reliable as CD63 expression in the diagnosis of cat allergy.

Annick Ocmant1, Yannick Peignois, Sandra Mulier, Laurence Hanssens, Alain Michils, Liliane Schandené.   

Abstract

The flow cytometric basophil activation test (BAT), based on the detection of allergen-induced CD63 expression, has been proved effective in the diagnosis of various IgE-mediated allergies. However, there is not yet consensus about the suitability of CD203c expression as a specific basophil activation marker and its diagnostic reliability. The goal of the present study was to compare measurement of CD63 and CD203c expression using BAT in a model of cat allergy and to determine optimal experimental conditions for both markers. Heparinized whole blood samples from 20 cat allergic patients and 19 controls were incubated with Fel d1 (relevant allergen) or anti-FcepsilonRI (positive control) either in IL-3 or IL-3-free conditions. An optimal gating of basophils was achieved in triple staining protocols: anti-IgE PE/anti-CD45 PerCP/anti-CD63 FITC or anti-IgE FITC/anti-CD45 PerCP/anti-CD203c PE. We demonstrated that IL-3 significantly enhanced CD63-induced expression by basophils obtained from cat allergic patients in response to Fel d1. Sensitivity was found to be 100%. The CD203c protocol, when performed under IL-3-free conditions, also demonstrated 100% sensitivity. Only one of the control subjects was positive in both tests. In conclusion, using well-defined experimental conditions, the measurement of CD203c up-regulation on basophils in response to specific allergens is as reliable as CD63-BAT for the in vitro diagnosis of patients with IgE-mediated allergy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17275019     DOI: 10.1016/j.jim.2006.12.002

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  25 in total

1.  Basophil CD203c levels are increased at baseline and can be used to monitor omalizumab treatment in subjects with nut allergy.

Authors:  Yael Gernez; Rabindra Tirouvanziam; Grace Yu; Eliver E B Ghosn; Neha Reshamwala; Tammie Nguyen; Mindy Tsai; Stephen J Galli; Leonard A Herzenberg; Leonore A Herzenberg; Kari C Nadeau
Journal:  Int Arch Allergy Immunol       Date:  2010-10-25       Impact factor: 2.749

2.  Increased IL-5 and IL-13 cytokine level in ex vivo stimulated whole blood cells from grass pollen allergic donors correlate with seasonal exposure.

Authors:  Anurag Singh; Sébastien Holvoet; Marietta Weiss; Maurice Beaumont; Adrian W Zuercher; Annick Mercenier
Journal:  Results Immunol       Date:  2011-07-27

3.  Delayed clinical and ex vivo response to mammalian meat in patients with IgE to galactose-alpha-1,3-galactose.

Authors:  Scott P Commins; Hayley R James; Whitney Stevens; Shawna L Pochan; Michael H Land; Carol King; Susan Mozzicato; Thomas A E Platts-Mills
Journal:  J Allergy Clin Immunol       Date:  2014-03-20       Impact factor: 10.793

4.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

5.  Clinical safety of Food Allergy Herbal Formula-2 (FAHF-2) and inhibitory effect on basophils from patients with food allergy: Extended phase I study.

Authors:  Sangita P Patil; Julie Wang; Ying Song; Sally Noone; Nan Yang; Sylvan Wallenstein; Hugh A Sampson; Xiu-Min Li
Journal:  J Allergy Clin Immunol       Date:  2011-07-26       Impact factor: 10.793

6.  Microparticles in nasal lavage fluids in chronic rhinosinusitis: Potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease.

Authors:  Toru Takahashi; Atsushi Kato; Sergejs Berdnikovs; Whitney W Stevens; Lydia A Suh; James E Norton; Roderick G Carter; Kathleen E Harris; Anju T Peters; Kathryn E Hulse; Leslie C Grammer; Kevin C Welch; Stephanie Shintani-Smith; Bruce K Tan; David B Conley; Robert C Kern; Bruce S Bochner; Robert P Schleimer
Journal:  J Allergy Clin Immunol       Date:  2017-02-24       Impact factor: 10.793

7.  IgG antibodies produced during subcutaneous allergen immunotherapy mediate inhibition of basophil activation via a mechanism involving both FcgammaRIIA and FcgammaRIIB.

Authors:  Carol T Cady; Maree S Powell; Ronald J Harbeck; Patricia C Giclas; James R Murphy; Rohit K Katial; Richard W Weber; P Mark Hogarth; Syd Johnson; Ezio Bonvini; Scott Koenig; John C Cambier
Journal:  Immunol Lett       Date:  2009-12-30       Impact factor: 3.685

8.  Basophil sensitivity through CD63 or CD203c is a functional measure for specific immunotherapy.

Authors:  Susan Mikkelsen; Bo Martin Bibby; Mette Konow Bøgebjerg Dolberg; Ronald Dahl; Hans Jürgen Hoffmann
Journal:  Clin Mol Allergy       Date:  2010-02-16

9.  Allergen-specific basophil suppression associated with clinical tolerance in patients with milk allergy.

Authors:  Niya Wanich; Anna Nowak-Wegrzyn; Hugh A Sampson; Wayne G Shreffler
Journal:  J Allergy Clin Immunol       Date:  2009-04       Impact factor: 10.793

10.  Inhibition of CD203c membrane up-regulation in human basophils by high dilutions of histamine: a controlled replication study.

Authors:  Salvatore Chirumbolo; Maurizio Brizzi; Riccardo Ortolani; Antonio Vella; Paolo Bellavite
Journal:  Inflamm Res       Date:  2009-05-06       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.